Microglial cells in neurodegenerative disorders

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Microglia are the primary immune cells residing in the central nervous system (CNS).
• These cells play a critical role in the pathogenesis of various neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), prion diseases, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and AIDS dementia complex.
• It is widely accepted that microglia contribute to neurodegeneration via the release of proinflammatory substances.

Purpose of the Study:

• To review the current understanding of microglial cell involvement in the development of Alzheimer's disease, Parkinson's disease, and prion diseases.
• To highlight the complex interactions between microglia and other CNS cell populations in the context of neuroinflammation and disease pathology.

Main Methods:

• Literature review of existing research on microglial function in neurodegenerative diseases.
• Analysis of the role of proinflammatory mediators released by microglia.
• Examination of intercellular communication within the CNS during pathological conditions.

Main Results:

• Microglia are key players in CNS immune responses and disease progression.
• The release of proinflammatory substances by microglia is a significant factor in neurodegeneration.
• Interactions among various CNS cell types modulate microglial responses and contribute to overall brain pathology.

Conclusions:

• Microglia significantly contribute to the pathogenesis of AD, PD, and prion diseases.
• Understanding the complex interplay between microglia and other CNS cells is crucial for deciphering brain pathology.
• Targeting microglial activation and their inflammatory pathways may offer therapeutic strategies for neurodegenerative disorders.